Haemonetics
Focus: Haemonetics is a Boston-based biotechnology company specializing in blood management solutions across cardiovascular, oncology, and infectious disease indications. The company operates a diversified portfolio of diagnostic and therapeutic programs focused on coagulation monitoring and blood collection/processing technologies.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Haemonetics
AI assessmentNot HiringNo open roles listed right now. Follow Haemonetics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
22 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growth
Core diagnostic platform with multiple cartridge variants (TEG 6s Citrated K/KH/RTH/FFH, DOAC, RapidTEG) supporting clinical decision-making in surgery and acute care.
MCS+ 8150 Blood Collection System
Help build intelligence for Haemonetics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.